Purpose of the Study

Helios Clinical Research is conducting a clinical study for adults ages 60 to 85 with mild to moderate Alzheimer’s disease. The purpose of this study is to evaluate an investigational drug for memory and thinking changes associated with mild to moderate Alzheimer’s disease. Some participants will receive the study drug, and some will receive placebo. A caregiver or study partner is required to attend study visits and help provide information about the participant’s daily functioning.

Study Requirements

Your loved one may qualify if they:

Are 60 to 85 years of age
Have been diagnosed with mild to moderate Alzheimer’s disease
Have a caregiver or study partner who can attend study visits
Meet other study criteria

Potential Benefits of Participation

Maginfying

Access to new treatments that are
not yet available to the general public.

Hand Heart

Personalized medical attention from
leading healthcare professionals.

Helios

Compensation provided to qualified participants

Study Locations

These studies are currently enrolling at the following sites:

Advanced Clinical Institute Powered by Helios - West Long Branch, NJ

About Helios Clinical

Helios Clinical is dedicated to advancing medical research through innovative clinical trials.
Our mission is to discover new ways to improve patient health and outcomes.
We collaborate with leading healthcare professionals and scientists
to ensure the highest standards of research and care for our participants.